Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $2.50.
CRLBF has been the topic of several research reports. Roth Capital upgraded Cresco Labs to a “strong-buy” rating in a research note on Sunday, November 10th. Cormark lowered shares of Cresco Labs from a “moderate buy” rating to a “hold” rating in a research note on Monday, November 11th. Ventum Cap Mkts upgraded Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th.
View Our Latest Report on Cresco Labs
Cresco Labs Stock Down 2.0 %
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Further Reading
- Five stocks we like better than Cresco Labs
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- How to invest in marijuana stocks in 7 stepsÂ
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What is the Shanghai Stock Exchange Composite Index?
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.